Brief: NeuroSearch to transfer drug candidates ACR325 and ACR343 to Saniona

NTG Nordic Transport AS

31/05/2016 11:52

May 31 (Reuters) - NeuroSearch A/S  NEUR.CO : 
    * Signs agreement to transfer the two drug candidates ACR325 and ACR343 to Saniona 
 SANION.ST   
    * Gained ownership of two drug candidates in 2006 as part of acquisition of Swedish company 
Carlson Research 
    * Saniona assumes the costs of maintaining the patent rights to ACR325 and ACR343 
    * Says will not receive any cash or any other consideration in connection with signing of 
the agreement 
    * Under deal NeuroSearch is entitled to up to 20 percent of milestones and royalties that 
Saniona may obtain in connection with further development of two drugs as well as of any 
potential drugs based on them that may reach market 
    * Agreement does not affect previously released guidance for 2016 of operating loss in range 
of 4 million Danish crowns - 6 million Danish crowns  ($899,955.00)($599,970.00)   
 
Source text:  urn:newsml:reuters.com:*:nCSE6lSV 
Further company coverage:  NEUR.CO  
 
($1 = 6.6670 Danish crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))